Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.

Thiboutot, Diane M; Kircik, Leon; McMichael, Amy; Cook-Bolden, Fran E; Tyring, Stephen K; Berk, David R; Chang-Lin, Joan-En; Lin, Vince; Kaoukhov, Alexandre

Thiboutot, Diane M; Kircik, Leon; McMichael, Amy; Cook-Bolden, Fran E; Tyring, Stephen K; Berk, David R; Chang-Lin, Joan-En; Lin, Vince; Kaoukhov, Alexandre.

Afiliação

Thiboutot DM; Penn State Hershey Dermatology, Hershey, Pennsylvania.
Kircik L; DermResearch, LLC, Louisville, Kentucky.
McMichael A; Wake Forest Baptist Health, Department of Dermatology, Winston-Salem, North Carolina.
Cook-Bolden FE; Skin Specialty Dermatology, New York, New York.
Tyring SK; University of Texas Health Science Center, Department of Dermatology, Houston, Texas.
Berk DR; Allergan plc, Irvine, California.
Chang-Lin JE; Allergan plc, Irvine, California.
Lin V; Allergan plc, Irvine, California.
Kaoukhov A; Allergan plc, Irvine, California.

J Clin Aesthet Dermatol ; 9(10): 18-27, 2016 Oct.

Article em En | MEDLINE | ID: mdl-27847545

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Clin Aesthet Dermatol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google